The UK's regulator has granted new licences to a hub of biotech companies to allow them to continue manufacturing of groundbreaking gene and cell therapies at an innovative purpose-built ce
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.